Phil RackliffeTechnology ReviewFrom products to pathways: The new frontier of MedTech innovationIn a new column, Phil Rackliffe of GE HealthCare discusses the benefits of a pathway-driven approach to healthcare.June 19, 2026Page 1 of 1Top StoriesASTRO 2026ASTRO: Low-dose RT tied to fewer knee replacementsPatients who underwent low-dose RT had longer symptom relief, less joint deterioration, and lower disability risk.ASTRO 2026ASTRO: Ultra-low-dose RT controls myeloma bone painASTRO 2026ASTRO: Limb-sparing care now standard for extremity sarcomaASTRO 2026ASTRO: Siemens unveils Accela radiotherapy systemSponsor ContentFree Webinar: CT Contrast Injection Reimagined
